期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纤溶酶原激活物抑制因子1及其在肺纤维化中的作用 被引量：2

原文传递
导出
作者 马海玲 王献华 刘宏伟
机构地区 华北煤炭医学院病理教研室
出处 《中国煤炭工业医学杂志》 2010年第2期298-299,共2页 Chinese Journal of Coal Industry Medicine
基金 河北省自然科学基金(C2008001007) 国家安全监督总局(06-557)
关键词 纤溶酶原激活物抑制因子1 肺纤维化
分类号 R363.21 [医药卫生—病理学] R563 [医药卫生—呼吸系统]
  • 相关文献

参考文献15

  • 1Torres - Carrillo NM,Torres - Carrillo N,Vdzquez - Del Mereado M,et al. The -844 G /A PAI- 1 polymorphism is associated with mRNA expression in rheumatoid arthritis[J]. Rheumatol Int,2008,28:355 - 360.
  • 2Kutz SM, Nickey SA, White LA, et al. Induced PAI- 1 mRNA expression and targeted protein accumulation are early G1 events in serumstimulated rat kidney cells[J]. J Cell Physiol,1997,170:8- 18.
  • 3Shetty S, Idell S. Posttranscriptional regulation of plasminogen activator inhibitor - 1 in human tung carcinoma cells in vitro[J]. Am J Physiol Lung Cell Mol Physiot, 2000, 278: L148- L156.
  • 4Andrew AS, Klei LR, Barchowsky A. AP - 1 - dependent induction of plasminogen activator inhibitor - 1 by nickel dose not require reactive oxygen[J]. Am J Physiol Lung Cell Mol Physio1,2001,281 : L616 - L623.
  • 5Furukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts[J]. Hepatology, 2003,38 : 879 - 889.
  • 6H attori N, Mizuno S, Yoshida Y, et al. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factordependent mechanism[J]. Am J Pathot,2004, 164:1091 - 1098.
  • 7Takeshita K, H ayashi M, Iino S, et al. Increased expression of plasminogen activator inhibitor- 1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction[J]. Am J Pathol,2004,164 : 449 - 456.
  • 8Inomata S, Takahashi H, Nagata M, et al. Acute lung injury as an adverse event of gefitinib[J]. Anticancer Drugs, 2004, 15:461 - 467.
  • 9Hattori N , Mizuno S, Yoshida Y, et al. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factordependent meehanism[J]. Am J Pathol,2004, 164 : 1091 - 1098.
  • 10李杨,宋良文,王德文,彭瑞云,高亚兵,马俊杰.γ射线对肺成纤维细胞中转录因子SP1,AP1和Smad3-Smad4活性的影响及意义[J].中华放射医学与防护杂志,2005,25(4):329-332. 被引量：3

二级参考文献49

共引文献8

同被引文献30

  • 1张秋娣.PAI-1与支气管哮喘[J].临床肺科杂志,2006,11(4):502-503. 被引量：1
  • 2孙秀娜,田莉莉.组织型纤溶酶原激活剂及其抑制剂与肺血栓栓塞症[J].国际呼吸杂志,2007,27(8):598-601. 被引量：2
  • 3周旋,夏曙华,晏家益,张小蕾,王正荣,莫非.uPA、uPAR、PAI-1血浆含量与卵巢恶性肿瘤的相关性研究[J].临床检验杂志,2007,25(4):269-270. 被引量：3
  • 4Gils A, Declerck PJ. The structural basis for the pathophyisiologJcal rel- evance of PAI - 1 in cardiovascular diseases and development of potential PAI- 1 inhibitors [ J ~. Thromb Haemost,2004,91 ( 3 ) :425 - 437.
  • 5Lilja H, Vickers A, Scardino P. Measurements of proteases or protease system components in blood to enhance prediction of disease risk or outcome in possible cancer [ J ]. J Clin Oneal, 2007, 25 (4) : 347 - 348.
  • 6Harbeck N, Kates RE, Schmitt M, et al. Urokinase - type plasmino- gen activator and its inhibitor type 1 predict disease outcome and therapy response inprimary breast cancer[J]. Clin Breast Cancer,2004, 5 (5) :348 - 352.
  • 7Shariat SF, Roehrbom CG, McConneU JD, et al. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metasta- sis[J]. J Chn Oncol, 2007, 25(4) : 349 - 355.
  • 8Ince DA, Atac FB, Ozkiraz S, et al. The role of plasminogen activator inhibitor - 1 and angiotensin - converting enzyme gene polymorphisms in bronchopulmonary dysplasia [ J]. Genet Test Mol Biomarkem, 2010, 14(5) : 643 -647.
  • 9Nielsen HJ, Christensen I J, Sorensen S, et al. Preoperative plasma plasminogen activator inhibitor type - 1 and serum C - reactive protein levels in patients with eolorectal cancer[ J]. Ann Surg Oneol, 2000, 7 (8) :617 -623.
  • 10Eddy AA. Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost, 2009,101 : 656-664.

引证文献2

二级引证文献8

中国煤炭工业医学杂志
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部